Diflorasone Diacetate NDC 51672-1295

NDC codes

FDA NDC Directory

Product NDC (as listed)51672-1295Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51672-1295Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
51672-1295-1	51672129501	1 TUBE in 1 CARTON (51672-1295-1) / 15 g in 1 TUBEMarketed from May 14, 1999
51672-1295-2	51672129502	1 TUBE in 1 CARTON (51672-1295-2) / 30 g in 1 TUBEMarketed from May 14, 1999
51672-1295-3	51672129503	1 TUBE in 1 CARTON (51672-1295-3) / 60 g in 1 TUBEMarketed from May 14, 1999

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Diflorasone Diacetate
Generic name (nonproprietary): diflorasone diacetate
Active ingredients: Diflorasone diacetate — .5 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Sun Pharmaceutical Industries, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075331
Marketing start: May 14, 1999
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 51672-1295_39095d21-70bb-6f1d-e063-6394a90a9b9dSPL ID 39095d21-70bb-6f1d-e063-6394a90a9b9dSPL set ID b304dfca-e840-4c03-8217-73aaa5360277RxCUI 966607UNII 7W2J09SCWX
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451672129501 followed by a unit qualifier and the quantity

Package 51672-1295-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 3, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Topical corticosteroids are indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)